Provention Bio, Inc. (PRVB) Social Stream
PROVENTION BIO INC (PRVB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PROVENTION BIO INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-09 | 5 | $25 | $16 | $19.875 | $23.95 | -17.01% |
| 2022-05-20 | 5 | $25 | $12 | $18.3 | $23.95 | -23.59% |
| 2022-08-04 | 5 | $22.5 | $12 | $16.9 | $23.95 | -29.44% |
| 2022-08-06 | 5 | $21 | $10 | $16.2 | $23.95 | -32.36% |
| 2022-08-24 | 5 | $21 | $10 | $15.8 | $23.95 | -34.03% |
| 2022-10-06 | 6 | $21 | $10 | $14.833 | $23.95 | -38.07% |
| 2022-10-07 | 6 | $21 | $10 | $15.666 | $23.95 | -34.59% |
| 2022-11-04 | 6 | $24 | $10 | $16.166 | $23.95 | -32.5% |
| 2022-11-06 | 6 | $24 | $10 | $16.666 | $23.95 | -30.41% |
| 2022-11-08 | 6 | $24 | $12 | $17 | $23.95 | -29.02% |
| 2022-11-17 | 6 | $24 | $12 | $17.666 | $23.95 | -26.24% |
| 2022-11-21 | 6 | $24 | $16 | $18.333 | $23.95 | -23.45% |
| 2023-02-15 | 6 | $30 | $16 | $20.5 | $23.95 | -14.41% |
| 2023-03-13 | 5 | $25 | $16 | $19.6 | $23.95 | -18.16% |
| 2023-03-15 | 6 | $25 | $16 | $22.5 | $23.95 | -6.05% |
The Trend in the Analyst Price Target
Over the past 26 months, PRVB's average price target has gone down $6.5.
Over the past 46 weeks, PRVB's average upside potential has been 182.73%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-04 | 5 | 22.5 | 12 | 16.900 | 4.28 | 294.86% |
| 2022-08-08 | 5 | 21.0 | 10 | 15.800 | 4.67 | 238.33% |
| 2022-12-19 | 6 | 30.0 | 16 | 20.500 | 8.86 | 131.38% |
| 2023-02-15 | 6 | 30.0 | 16 | 20.166 | 9.65 | 108.97% |
| 2023-03-15 | 6 | 25.0 | 16 | 22.500 | 23.91 | -5.9% |
PRVB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.33 | 2 | 0 | 4 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
PRVB's average broker recommendation rating worsened by 0.8 over the prior 35 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PRVB as an investment opportunity.
- PROVENTION BIO INC's upside potential (average analyst target price relative to current price) is greater than 40.8% of all US stocks.
- PRVB has a higher average analyst price target than 426.46% of all US stocks.
- In the context of stocks in the small market cap category, PROVENTION BIO INC's number of analysts covering the stock is higher than 1319.39% of them.
- In the context of stocks in the small market cap category, PROVENTION BIO INC's variance in analysts' estimates is lower than -1156.45% of them.
In the Pharmaceutical Products industry, CRNX, MGTA, and APTX are the three stocks most similar to PROVENTION BIO INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding PRVB using the data that counts. Try POWR Ratings for free.